inosine-pranobex and Carcinoma--Squamous-Cell

inosine-pranobex has been researched along with Carcinoma--Squamous-Cell* in 2 studies

Trials

1 trial(s) available for inosine-pranobex and Carcinoma--Squamous-Cell

Article	Year
Immunotherapy as an adjuvant to surgery in carcinoma of bronchus. Results in three randomised trials. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 1989, Volume: 3, Issue:5 The results of non-specific immunotherapy adjuvant to surgery in the treatment of non-small cell lung cancer were studied in three separate randomised clinical trials involving 344 patients. The first study involved 126 patients. In 73, intrapleural BCG was given according to McKneally's technique. They were compared to a control group of 63 patients. In the second trial, levamisole was administered to 43 patients who, in addition to surgery, also had radiotherapy. These were compared with 43 control patients. In the third study, 60 patients underwent surgical operation for limited lesions and in addition received Isoprinosine. These were compared with a control group of 60 patients. All patients in the control groups of the three studies had similar surgical operations to their treated counterpart. The overall results showed no difference between those who received immunotherapy and the control groups of patients and that the use of these agents did not alter either the course of the disease or the incidence of its recurrence. Topics: Adenocarcinoma; Adjuvants, Immunologic; BCG Vaccine; Bronchial Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Injections; Inosine Pranobex; Isoniazid; Levamisole; Placebos; Pleura; Randomized Controlled Trials as Topic; Survival Rate	1989

Article

Year

Immunotherapy as an adjuvant to surgery in carcinoma of bronchus. Results in three randomised trials.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 1989, Volume: 3, Issue:5

The results of non-specific immunotherapy adjuvant to surgery in the treatment of non-small cell lung cancer were studied in three separate randomised clinical trials involving 344 patients. The first study involved 126 patients. In 73, intrapleural BCG was given according to McKneally's technique. They were compared to a control group of 63 patients. In the second trial, levamisole was administered to 43 patients who, in addition to surgery, also had radiotherapy. These were compared with 43 control patients. In the third study, 60 patients underwent surgical operation for limited lesions and in addition received Isoprinosine. These were compared with a control group of 60 patients. All patients in the control groups of the three studies had similar surgical operations to their treated counterpart. The overall results showed no difference between those who received immunotherapy and the control groups of patients and that the use of these agents did not alter either the course of the disease or the incidence of its recurrence.

Topics: Adenocarcinoma; Adjuvants, Immunologic; BCG Vaccine; Bronchial Neoplasms; Carcinoma, Squamous Cell; Combined Modality Therapy; Humans; Injections; Inosine Pranobex; Isoniazid; Levamisole; Placebos; Pleura; Randomized Controlled Trials as Topic; Survival Rate

1989

Other Studies

1 other study(ies) available for inosine-pranobex and Carcinoma--Squamous-Cell

Article	Year
Immunologic alterations and active aspecific immunotherapy in lung cancer patients. The Italian journal of surgical sciences, 1983, Volume: 13, Issue:2 An immunologic study was undertaken on 89 lung cancer patients and on the basis of results obtained so far, a protocol of active, aspecific immunotherapy by living bacterial vaccines (BCG) and/or synthetic immunopotentiator (methisoprinol) was carried out. First results obtained in patients undergoing immunostimulation are reported together with the observation that while positive humoral effects seem present in stage I and II patients, in cases of spread of the disease results are substantially negative. Topics: Adenocarcinoma; Adult; BCG Vaccine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Humans; Immunoglobulins; Immunotherapy; Inosine; Inosine Pranobex; Lung Neoplasms; Lymphocyte Activation; Male; Middle Aged; Rosette Formation	1983

Article

Year

Immunologic alterations and active aspecific immunotherapy in lung cancer patients.

The Italian journal of surgical sciences, 1983, Volume: 13, Issue:2

An immunologic study was undertaken on 89 lung cancer patients and on the basis of results obtained so far, a protocol of active, aspecific immunotherapy by living bacterial vaccines (BCG) and/or synthetic immunopotentiator (methisoprinol) was carried out. First results obtained in patients undergoing immunostimulation are reported together with the observation that while positive humoral effects seem present in stage I and II patients, in cases of spread of the disease results are substantially negative.

Topics: Adenocarcinoma; Adult; BCG Vaccine; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Humans; Immunoglobulins; Immunotherapy; Inosine; Inosine Pranobex; Lung Neoplasms; Lymphocyte Activation; Male; Middle Aged; Rosette Formation

1983